首页 > 市场调查报告书 > 製药

生技设备生物工艺

市场调查报告书

商品编码

1375206

欧洲生物製程技术市场预测至 2028 年 - 按类型、模式和最终用户进行的区域分析

Europe Bioprocess Technology Market Forecast to 2028 - Regional Analysis By Type, Modality, and End User

出版日期: 2023年09月14日 | 出版商:

The Insight Partners | 英文 143 Pages | 订单完成后即时交付

价格

简介目录图表

欧洲生物製程技术市场预计将从2023年的122.9088亿美元成长到2028年的265.8836亿美元。预计2023年至2028年复合年增长率为16.7%。

引进先进的生物製程技术推动欧洲生物製程技术市场

先进的生物製程技术将研发与生产连结起来。一些参与者正在市场上引入各种新的生物加工技术。 2020 年 12 月 4 日，IDBS（生物技术和製药行业软体资讯学解决方案提供商）宣布推出 Polar。 Polar 创建了一个名为生物製药生命週期管理 (BPLM) 的新产品类别，以简化生物製药研究中的药物开发和生产。 Polar 的设计和部署旨在快速解决与工作流程、流程品质、协作和资料分析相关的挑战，这些挑战一直困扰着现有的软体解决方案，包括实验室资讯管理系统(LIMS) 和电子实验室笔记本(ELN)。因此，人为错误将会减少，整体准确度也会提高。它将减少手动资料处理和转录，从而减少人为错误并提高整体准确性。它还具有广泛的搜寻功能，使用户可以更轻鬆地找到他们正在搜寻的内容，从而避免无意义的重复工作。

梅特勒-托利多的 Dynochem Biologics 是一款专用模拟软体，支援任何规模的生物加工中的上游和下游单元活动。生物製程工程师和科学家使用该软体选择适当的製程操作参数并建立等效规模。实用程式可以用最少的资料快速评估设备性能，而更有效的模型则利用现有的资料流进行製程表征。透过快速回应的应用专业知识、丰富的培训资源和已建置的模型库，可以快速完成初始专案。胜肽、单株抗体、疫苗接种和病毒载体只是众多应用中的几个例子。

默克的全新 BioContinuum 平台透过提高效率、简化工厂运作以及更高的品质和一致性来推进生物治疗药物的生产。此外，默克的 Pellicon 单通道切向流过滤有助于强化与治疗性蛋白质纯化相关的操作。因此，各种新时代生物工艺技术的引入可能会在预测期内为市场成长提供利润丰厚的机会。

欧洲生物工艺技术市场概况

据德国贸易投资总署称，该国是第二大医药产品出口国，并跻身全球顶级医药生产国之列。由于个人化医疗需求的不断增长，德国也已发展成为新型生物製药的主要供应国之一。生物製剂因其高治疗潜力而在德国医药市场占有相当大的份额。根据德国贸易投资总署（GTAI）的报告，2015年至2019年，生物製剂市场年均成长11.6%（是整个製药市场成长的两倍多）。 2019年德国生物製药总收入为139.6亿美元，相当于医药市场的四分之一以上。德国拥有欧洲主要的医药市场，也是全球第四大医药市场。 2019年，德国製药业销售额较2018年成长5.7%，达510.1亿美元（出厂价）。德国有超过 500 家製药公司。中小企业是经济部门的支柱，约 90% 的药厂员工人数不到 500 人。因此，欧洲不断增长的製药市场将推动生物製程技术的使用，因为生物技术有助于製药公司开发新产品、製程、方法和服务并改进现有产品、製程、方法和服务。

欧洲生物工艺技术市场收入及 2028 年预测（百万美元）

欧洲生物工艺技术市场细分

欧洲生物工艺技术市场按类型、模式、最终用户和国家进行细分。

根据类型，欧洲生物製程技术市场分为细胞培养基生物製程、色谱生物製程以及消耗品和配件等。 2023年，消耗品和配件领域在欧洲生物製程技术市场中占据最大份额。

根据模式，欧洲生物加工技术市场分为一次性使用和多次使用。 2023年，一次性使用领域在欧洲生物製程技术市场中占有更大份额。

根据最终用户，欧洲生物製程技术市场分为学术和医疗机构、生物製药公司、研究实验室等。 2023年，生物製药公司领域在欧洲生物製程技术市场中占最大份额。

根据国家/地区，欧洲生物工艺技术市场分为英国、德国、法国、义大利、西班牙和欧洲其他地区。 2023年，德国市场在欧洲生物製程技术市场中占有最大份额。

生物製药动力股份有限公司；康宁公司；丹纳赫公司；艾本德公司；龙沙集团股份公司；默克公司；雷普利根公司；赛多利斯公司；斯塔姆生物技术公司；和 Thermo Fisher Scientific Inc 是欧洲生物製程技术市场的领先公司。

Advanced bioprocess technologies bridge R&D with production. Several players are introducing a wide range of new bioprocessing technologies in the market. On December 4, 2020, IDBS (a provider of software informatics solutions for the biotech and pharmaceutical industries) announced the launch of Polar. Polar creates a new product category called BioPharma Lifecycle Management (BPLM) to streamline drug development and production in biopharma research. Polar is designed and deployed to rapidly solve challenges associated with workflow, process quality, collaboration, and data analysis that have plagued the existing software solutions, including laboratory information management system (LIMS) and electronic laboratory notebook (ELN). As a result, there will be less human errors and an improvement in overall accuracy. It will reduce manual data processing and transcription, leading to fewer human errors and enhanced overall accuracy. It also has extensive search features that make it easier for users to locate what they are searching for, preventing the need for pointless duplication of effort.

METTLER TOLEDO's Dynochem Biologics is a purpose-built simulation software that supports upstream and downstream unit activities in bioprocessing at any scale. Bioprocess engineers and scientists use the software to choose appropriate process operating parameters and establish scales equivalency. Utilities enable quick evaluation of equipment performance with minimal data, whereas more potent models leverage the existing data streams for process characterization. Initial projects can be completed quickly with the help of responsive application expertise, rich training resources, and a model library that is already built. Peptides, mAbs, vaccinations, and viral vectors are a few examples of the many applications.

Merck's new BioContinuum Platform advances biotherapeutic drug manufacturing through improved efficiency, simplified plant operations, and greater quality and consistency. In addition, Merck's Pellicon Single-Pass Tangential Flow Filtration aid in intensifying operations associated with the purification of therapeutic proteins. Thus, the introduction of various new-age bioprocess technologies is likely to provide lucrative opportunities for the market growth during the forecast period.

Europe Bioprocess Technology Market Overview

According to Germany Trade & Invest, the country is the second largest exporter of medicinal products and ranks among the top pharmaceutical producers across the world. Owing to the rising demand for personalized medicine, Germany has also evolved into one of the main suppliers of novel biopharmaceuticals. Biologics hold a considerable share of the pharmaceutical market in Germany due to their high therapeutic potential. According to a report by Germany Trade & Invest (GTAI) from 2015 to 2019, the biologics market grew by 11.6 % on average annually (more than twice the growth of the overall pharma market). The total revenue of biopharmaceuticals in Germany was US$ 13.96 billion in 2019, equivalent to more than a quarter of the pharmaceutical market. Germany has a major European pharmaceutical market and is the fourth largest across the world. In 2019, sales in the pharmaceutical industry in Germany increased by 5.7 %, from 2018, reaching US$ 51.01 billion (ex-manufacturer prices). More than 500 pharmaceutical companies are located in Germany. SMEs are the backbone of the economic sector, with around 90% of drug manufacturers having less than 500 employees. Thus, the growing pharmaceutical market in Europe will propel the use of bioprocess technology as biotechnology helps the pharmaceutical companies develop new products, processes, methods, and services and improve existing ones.

Europe Bioprocess Technology Market Revenue and Forecast to 2028 (US$ Million)

Europe Bioprocess Technology Market Segmentation

The Europe bioprocess technology market is segmented into type, modality, end user, and country.

Based on type, the Europe bioprocess technology market is segmented into cell culture media bioprocess, chromatography bioprocess, and consumables & accessories, and others. In 2023, the consumables & accessories segment registered the largest share in the Europe bioprocess technology market.

Based on modality, the Europe bioprocess technology market is bifurcated into single use and multiple use. In 2023, the single use segment registered a larger share in the Europe bioprocess technology market.

Based on end user, the Europe bioprocess technology market is segmented into academic & medical institutions, biopharmaceutical companies, research laboratories, and others. In 2023, the biopharmaceutical companies segment registered the largest share in the Europe bioprocess technology market.

Based on country, the Europe bioprocess technology market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. In 2023, Germany segment registered a largest share in the Europe bioprocess technology market.

BioPharma Dynamics Ltd; Corning Inc; Danaher Corp; Eppendorf SE; Lonza Group AG; Merck KGaA; Repligen Corp; Sartorius AG; STAMM Biotech; and Thermo Fisher Scientific Inc are the leading companies operating in the Europe bioprocess technology market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe bioprocess technology market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Europe bioprocess technology market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the bioprocess technology market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Europe Bioprocess Technology Market - by Type
- 1.3.2 Europe Bioprocess Technology Market - by Modality
- 1.3.3 Europe Bioprocess Technology Market - by End User
- 1.3.4 Europe Bioprocess Technology Market - by Country

2. Europe Bioprocess Technology Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Bioprocess Technology Market - Market Landscape

4.1 Overview
4.2 Europe PEST Analysis
4.3 Expert's Opinion

5. Europe Bioprocess Technology Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Growing R&D Spendings to Introduce New Drug Compounds
- 5.1.2 Increasing Prevalence of Chronic Diseases
5.2 Market Restraints
- 5.2.1 Stringent Regulatory Policies
5.3 Market Opportunities
- 5.3.1 Introducing Advanced Bioprocess Technologies
5.4 Future Trends
- 5.4.1 Emergence of Automated Real?Time Flow Cytometry (ART?FCM)
5.5 Impact Analysis

6. Bioprocess Technology Market - Europe Analysis

6.1 Europe Bioprocess Technology Market Revenue Forecast and Analysis

7. Europe Bioprocess Technology Market - Revenue and Forecast to 2028 - by Type

7.1 Overview
7.2 Europe Bioprocess Technology Market Revenue Share, by Type 2022 & 2028 (%)
7.3 Cell Culture Media Bioprocess
- 7.3.1 Overview
- 7.3.2 Cell Culture Media Bioprocess: Europe Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Chromatography Bioprocess
- 7.4.1 Overview
- 7.4.2 Chromatography Bioprocess: Europe Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Consumables & Accessories
- 7.5.1 Overview
- 7.5.2 Consumables & Accessories: Europe Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
7.6 Others
- 7.6.1 Overview
- 7.6.2 Others: Europe Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)

8. Europe Bioprocess Technology Market Analysis and Forecasts to 2028 - by Modality

8.1 Overview
8.2 Europe Bioprocess Technology Market, by Modality 2022 & 2028 (%)
8.3 Single Use
- 8.3.1 Overview
- 8.3.2 Single Use: Europe Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Multiple Use
- 8.4.1 Overview
- 8.4.2 Multiple Use: Europe Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)

9. Europe Bioprocess Technology Market - Revenue and Forecast to 2028 - by End User

9.1 Overview
9.2 Europe Bioprocess Technology Market Revenue Share, by End User 2022 & 2028 (%)
9.3 Academic & Medical Institutions
- 9.3.1 Overview
- 9.3.2 Academic & Medical Institutions: Europe Bioprocess Technology Market - Revenue and Forecast to 2028(US$ Million)
9.4 Biopharmaceutical Companies
- 9.4.1 Overview
- 9.4.2 Biopharmaceutical Companies: Europe Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Research Laboratories
- 9.5.1 Overview
- 9.5.2 Research Laboratories: Europe Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: Europe Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)

10. Europe Bioprocess Technology Market - Revenue and Forecast to 2028 - Country Analysis

10.1 Overview
- 10.1.1 Europe: Bioprocess Technology Market, by Country, 2022 & 2028 (%)
  - 10.1.1.1 Germany: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.1.1 Overview
    - 10.1.1.1.2 Germany: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.1.3 Germany: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
    - 10.1.1.1.4 Germany: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
    - 10.1.1.1.5 Germany: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
  - 10.1.1.2 UK: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.2.1 Overview
    - 10.1.1.2.2 UK: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.2.3 UK: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
    - 10.1.1.2.4 UK: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
    - 10.1.1.2.5 UK: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
  - 10.1.1.3 France: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.3.1 Overview
    - 10.1.1.3.2 France: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.3.3 France: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
    - 10.1.1.3.4 France: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
    - 10.1.1.3.5 France: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
  - 10.1.1.4 Italy: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.4.1 Overview
    - 10.1.1.4.2 Italy: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.4.3 Italy: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
    - 10.1.1.4.4 Italy: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
    - 10.1.1.4.5 Italy: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
  - 10.1.1.5 Spain: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.5.1 Overview
    - 10.1.1.5.2 Spain: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.5.3 Spain: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
    - 10.1.1.5.4 Spain: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
    - 10.1.1.5.5 Spain: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
  - 10.1.1.6 Rest of Europe: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.6.1 Overview
    - 10.1.1.6.2 Rest of Europe: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.6.3 Rest of Europe: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
    - 10.1.1.6.4 Rest of Europe: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
    - 10.1.1.6.5 Rest of Europe: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)

11. Europe Bioprocess Technology Market - Industry Landscape

11.1 Overview
11.2 Organic Growth Strategies
- 11.2.1 Overview
11.3 Inorganic Growth Strategies
- 11.3.1 Overview

12. Company Profiles

12.1 Merck KGaA
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Sartorius AG
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Thermo Fisher Scientific Inc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Corning Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Lonza Group AG
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Eppendorf SE
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Repligen Corp
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Danaher Corp
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 BioPharma Dynamics Ltd
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms

简介目录图表

List Of Tables

Table 1. Europe Bioprocess Technology Market, Revenue and Forecast, 2020-2028 (US$ Million)
Table 2. Germany Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 3. Germany Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 4. Germany Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 5. UK Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 6. UK Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 7. UK Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 8. France Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 9. France Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 10. France Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 11. Italy Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 12. Italy Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 13. Italy Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 14. Spain Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 15. Spain Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 16. Spain Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 17. Rest of Europe Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 18. Rest of Europe Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 19. Rest of Europe Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 20. Recent Organic Growth Strategies in Bioprocess Technology Market
Table 21. Recent Inorganic Growth Strategies in the Europe bioprocess technology market
Table 22. Glossary of Terms

List Of Figures

Figure 1. Europe Bioprocess Technology Market Segmentation
Figure 2. Europe Bioprocess Technology Market, by Country
Figure 3. Europe Bioprocess Technology Market Overview
Figure 4. Others Segment Held Largest Share of Type Segment in Europe Bioprocess Technology Market
Figure 5. UK Expected to Show Remarkable Growth During Forecast Period
Figure 6. Europe: PEST Analysis
Figure 7. Experts' Opinion
Figure 8. Europe Bioprocess Technology Market Impact and Analysis
Figure 9. Europe Bioprocess Technology Market - Revenue Forecast and Analysis - 2020-2028
Figure 10. Europe Bioprocess Technology Market Revenue Share, by Type 2022 & 2028 (%)
Figure 11. Cell Culture Media Bioprocess: Europe Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 12. Chromatographic Bioprocess: Europe Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 13. Consumables & Accessories: Europe Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 14. Others: Europe Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 15. Europe Bioprocess Technology Market, by Modality 2022 & 2028 (%)
Figure 16. Single Use: Europe Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 17. Multiple Use: Europe Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 18. Europe Bioprocess Technology Market Revenue Share, by End User 2022 & 2028 (%)
Figure 19. Academic & Medical Institutions: Europe Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 20. Biopharmaceutical Companies: Europe Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 21. Research Laboratories: Europe Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 22. Others: Europe Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 23. Europe: Bioprocess Technology Market, by Key Country - Revenue (2022) (US$ Million)
Figure 24. Europe: Bioprocess Technology Market, by Country, 2022& 2028 (%)
Figure 25. Germany: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 26. UK: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 27. France: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 28. Italy: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 29. Spain: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
Figure 30. Rest of Europe: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)